Ahmad Bechara provides strategic insight on clinical trial design across several therapeutic areas, including cardiometabolic, hematology, oncology, and rare diseases. Ahmad has over 18 years of experience in both the pharmaceutical industry and academic research. He holds a PhD in genetics and neuroscience from the University of Claude Bernard in Lyon, where he researched the molecular mechanisms of topographic brain map formation and plasticity. His experience also includes positions at Wellmera and the Global Market Access Cardio-Metabolic franchise of Novartis Global. He has authored and co-authored multiple publications in the genetic, neuroscience, and market access fields.